Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.73
+0.27 (4.18%)
At close: Mar 31, 2026, 4:00 PM EDT
6.78
+0.05 (0.74%)
After-hours: Mar 31, 2026, 4:10 PM EDT

Kyntra Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
273653881,5091,310
Market Cap Growth
-38.06%-33.52%-38.95%-94.20%15.19%-61.39%
Enterprise Value
-41.9847.05176.89114.451,2351,013
Last Close Price
6.738.7813.2422.16400.50352.50
PE Ratio
0.150.19-1.11-0.30-5.10-4.49
PS Ratio
4.265.521.801.8710.725.57
PB Ratio
6.13-1.18-0.24-0.43-70.346.26
P/TBV Ratio
-0.91-1.18-0.23-0.42-69.906.23
P/FCF Ratio
--7.38-0.39-0.28-10.08-14.98
P/OCF Ratio
--7.44-0.39-0.28-10.34-15.93
EV/Sales Ratio
-7.315.972.458.784.31
EV/EBITDA Ratio
--1.04-1.20-0.37-4.25-3.70
EV/EBIT Ratio
--1.03-1.18-0.35-4.10-3.51
EV/FCF Ratio
--9.78-1.28-0.36-8.25-11.59
Debt / Equity Ratio
14.7414.74-0.72-1.16-87.110.39
Debt / EBITDA Ratio
-1.46-1.46-0.89-0.64-0.48-0.36
Debt / FCF Ratio
-13.71-13.71-0.95-0.63-0.93-1.14
Net Debt / Equity Ratio
0.770.77-0.360.0113.19-1.46
Net Debt / EBITDA Ratio
0.510.51-0.550.010.971.12
Net Debt / FCF Ratio
4.784.78-0.590.011.893.49
Asset Turnover
0.040.040.090.090.200.29
Inventory Turnover
0.160.161.530.140.570.54
Quick Ratio
3.053.050.380.961.601.87
Current Ratio
3.393.391.471.521.802.10
Return on Equity (ROE)
64.97%64.97%88.54%394.64%-258.76%-86.59%
Return on Assets (ROA)
-27.51%-27.51%-47.23%-62.49%-43.45%-36.01%
Return on Invested Capital (ROIC)
-88.71%-88.71%-179.11%-7289.76%-559.46%-344.89%
Return on Capital Employed (ROCE)
-53.50%-53.50%-104.79%-119.00%-68.04%-47.61%
Earnings Yield
668.62%516.74%-89.80%-329.42%-19.60%-22.27%
FCF Yield
-17.54%-13.54%-258.68%-362.70%-9.92%-6.68%
Buyback Yield / Dilution
-1.02%-1.02%-2.82%-3.98%-1.34%-2.78%
Total Shareholder Return
-1.02%-1.02%-2.82%-3.98%-1.34%-2.78%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.